Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.14 Billion CNY | 16.55% |
| 2022 | 983.04 Million CNY | 26.34% |
| 2021 | 778.1 Million CNY | 40.5% |
| 2020 | 553.82 Million CNY | 31.04% |
| 2019 | 422.64 Million CNY | 30.68% |
| 2018 | 323.42 Million CNY | 28.94% |
| 2017 | 250.82 Million CNY | 43.71% |
| 2016 | 174.53 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 281.06 Million CNY | -6.75% |
| 2024 Q3 | 264.54 Million CNY | -5.88% |
| 2024 Q1 | 301.4 Million CNY | -10.45% |
| 2023 Q3 | 250.69 Million CNY | -10.67% |
| 2023 Q1 | 277.79 Million CNY | -10.27% |
| 2023 FY | 1.14 Billion CNY | 16.55% |
| 2023 Q4 | 336.58 Million CNY | 34.26% |
| 2023 Q2 | 280.63 Million CNY | 1.02% |
| 2022 Q3 | 226.59 Million CNY | -4.34% |
| 2022 Q2 | 236.86 Million CNY | 12.8% |
| 2022 Q1 | 209.98 Million CNY | -10.28% |
| 2022 FY | 983.04 Million CNY | 26.34% |
| 2022 Q4 | 309.6 Million CNY | 36.64% |
| 2021 Q3 | 187.97 Million CNY | -1.91% |
| 2021 FY | 778.1 Million CNY | 40.5% |
| 2021 Q4 | 234.05 Million CNY | 24.51% |
| 2021 Q2 | 191.64 Million CNY | 16.55% |
| 2021 Q1 | 164.43 Million CNY | 2.44% |
| 2020 Q4 | 160.51 Million CNY | 19.8% |
| 2020 Q3 | 133.98 Million CNY | -2.28% |
| 2020 Q1 | 122.21 Million CNY | -0.7% |
| 2020 FY | 553.82 Million CNY | 31.04% |
| 2020 Q2 | 137.1 Million CNY | 12.18% |
| 2019 Q2 | 110.61 Million CNY | 17.22% |
| 2019 FY | 422.64 Million CNY | 30.68% |
| 2019 Q4 | 123.07 Million CNY | 30.13% |
| 2019 Q3 | 94.58 Million CNY | -14.5% |
| 2019 Q1 | 94.36 Million CNY | -5.59% |
| 2018 Q4 | 99.95 Million CNY | 0.0% |
| 2018 FY | 323.42 Million CNY | 28.94% |
| 2017 FY | 250.82 Million CNY | 43.71% |
| 2016 FY | 174.53 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | 483.84 Million CNY | -136.796% |